Search

Search any products, services and so on here.

About 16311 result(s)

Global Lovastatin Market Research Report 2024

  • Jan 18, 24
  • ID: 3231
  • Pages: 82
  • Figures: 176
  • Views: 27
  • From $2,900

Lovastatin is a statin drug, used for lowering cholesterol in those with hypercholesterolemia to reduce risk of cardiovascular disease. The global Lovastatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Lovastatin is estimated to increase from $ million in 2023 to r...


Global Raltegravir Market Research Report 2024

  • Jan 18, 24
  • ID: 3232
  • Pages: 73
  • Figures: 164
  • Views: 25
  • From $2,900

Raltegravir (RAL), sold under the brand name Isentress, is an antiretroviral medication used, together with other medication, to treat HIV/AIDS. The global Raltegravir market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Raltegravir is estimated to increase from $ million i...


Global Pneumococcal Vaccine Polyvalent Market Research Report 2024

  • Jan 18, 24
  • ID: 3233
  • Pages: 68
  • Figures: 157
  • Views: 14
  • From $2,900

Pneumococcal vaccines are vaccines against the bacteria Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis. The global Pneumococcal Vaccine Polyvalent market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion US...


Global Montelukast Drug Market Research Report 2024

  • Jan 18, 24
  • ID: 3234
  • Pages: 108
  • Figures: 256
  • Views: 18
  • From $2,900

Montelukast is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies. The global Montelukast Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing a...


Global Daptomycin Market Research Report 2024

  • Jan 18, 24
  • ID: 3235
  • Pages: 90
  • Figures: 203
  • Views: 30
  • From $2,900

Daptomycin is a lipopeptide antibiotic used in the treatment of systemic and life-threatening infections caused by Gram-positive organisms. The global Daptomycin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Daptomycin is estimated to increase from $ million in 2023...


Global Infliximab and Biosimilar Market Research Report 2024

  • Jan 18, 24
  • ID: 3236
  • Pages: 70
  • Figures: 158
  • Views: 18
  • From $2,900

Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α) and is used to treat autoimmune diseases. The global Infliximab and Biosimilar market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmac...


Global Balsalazide Market Research Report 2024

  • Jan 18, 24
  • ID: 3237
  • Pages: 79
  • Figures: 180
  • Views: 32
  • From $2,900

Balsalazide is an oral anti-inflammatory drug that is used for the treatment of ulcerative colitis. The global Balsalazide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Balsalazide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR...


Global Methylphenidate Drug Market Research Report 2024

  • Jan 18, 24
  • ID: 3238
  • Pages: 98
  • Figures: 227
  • Views: 19
  • From $2,900

Methylphenidate Drug is a central nervous system stimulant prescription medicine. It is used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). The global Methylphenidate Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD...


Global Dexmethylphenidate Market Research Report 2024

  • Jan 18, 24
  • ID: 3239
  • Pages: 92
  • Figures: 206
  • Views: 18
  • From $2,900

Dexmethylphenidate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). The global Dexmethylphenidate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Dexmethylphenidate is estimated to increase from $ million in 2023 to reach $ million by...


Global Rivastigmine Market Research Report 2024

  • Jan 18, 24
  • ID: 3240
  • Pages: 95
  • Figures: 208
  • Views: 30
  • From $2,900

Rivastigmine (sold under the trade name Exelon) is a acetylcholinesterase inhibitor used for the treatment of mild to moderate Alzheimer's disease and Parkinson's. The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of side effects, which typically include nausea and vomiting. The global Rivastigmine market was valued at US$ million in 2023 and i...


Our team would be happy to assist you with your queries.

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232